Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-month Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and PK/PD of an age-and Body Weight-adjusted Oral Finerenone Regimen, in Addition to an ACEI or ARB, for the Treatment of Children, 6 Months to <18 Years of Age, With Chronic Kidney Disease and Proteinuria

NCT05196035 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT05196035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05196035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-month Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and PK/PD of an age-and Body Weight-adjusted Oral Finerenone Regimen, in Addition to an ACEI or ARB, for the Treatment of Children, 6 Months to <18 Years of Age, With Chronic Kidney Disease and Proteinuria
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Active, not recruiting
Start date
March 28, 2022
Completion date
May 10, 2027
Enrollment
219 (estimated)
Sites
132

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, proteinuria